Acyclovir
- Product NDC
- 50090-7275
- 11-digit product format
- 500907275
- Labeler code
- 50090
- Product ID
- 50090-7275_810fa4f4-8281-44c0-98c2-a3cc70098fab
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2023-06-20
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7275-2 | 50090727502 | 25 TABLET in 1 BOTTLE (50090-7275-2) | 25 tablet | 2024-10-08 | No | No | Historical |
| 50090-7275-3 | 50090727503 | 50 TABLET in 1 BOTTLE (50090-7275-3) | 50 tablet | 2024-10-08 | No | No | Historical |
| 50090-7275-4 | 50090727504 | 15 TABLET in 1 BOTTLE (50090-7275-4) | 15 tablet | 2024-10-08 | No | No | Historical |
| 50090-7275-5 | 50090727505 | 30 TABLET in 1 BOTTLE (50090-7275-5) | 30 tablet | 2024-10-08 | No | No | Historical |
| 50090-7275-6 | 50090727506 | 60 TABLET in 1 BOTTLE (50090-7275-6) | 60 tablet | 2024-10-08 | No | No | Historical |
| 50090-7275-9 | 50090727509 | 45 TABLET in 1 BOTTLE (50090-7275-9) | 45 tablet | 2024-10-08 | No | No | Historical |